[ Price : $8.95]
FDA releases a corrected version of a 12/30 Complete Response Letter issued to Corcept Therapeutics, indicating that the agency ha...[ Price : $8.95]
Ultragenyx Pharmaceutical resubmits a BLA seeking accelerated approval for UX111, an AAV9 gene therapy for the treatment of Sanfil...[ Price : $8.95]
Elevar Therapeutics files an NDA for lirafugratinib as a second-line treatment for patients with cholangiocarcinoma whose tumors h...[ Price : $8.95]
Sen. Rick Scott (R-FL) introduces legislation that would require prescription drug labels in the U.S. to disclose where drugs and ...[ Price : $8.95]
FDA discontinues the use of its Quality System Inspection Technique for medical device inspections and will instead conduct inspec...[ Price : $8.95]
Grail files the final module of its PMA for the companys multi-cancer early detection blood test.[ Price : $8.95]
FDA awards Biogen a breakthrough therapy designation for its experimental antibody litifilimab for treating cutaneous lupus erythe...[ Price : $8.95]
A group of Democratic senators ask HHS Office of Inspector General to clarify how it will oversee direct-to-consumer prescription ...